SCHEMBL6632086

SCHEMBL6632086

COC(=O)c1cc2c(Sc3ccccc3Br)cccc2[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.42
▸ KIF11 P52732 1/20 0.42
▸ HRH4 Q9H3N8 1/20 0.42
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ TUBB4A P04350 3/20 0.41
▸ TUBB P07437 3/20 0.41
▸ TUBA3C P0DPH7 3/20 0.41
▸ TUBA1B P68363 3/20 0.41
▸ TUBA4A P68366 3/20 0.41
▸ TUBB4B P68371 3/20 0.41
▸ TUBB3 Q13509 3/20 0.41
▸ TUBB2A Q13885 3/20 0.41
▸ TUBB8 Q3ZCM7 3/20 0.41
▸ TUBA3E Q6PEY2 3/20 0.41
▸ TUBA1A Q71U36 3/20 0.41
▸ TUBA1C Q9BQE3 3/20 0.41
▸ TUBB6 Q9BUF5 3/20 0.41
▸ TUBB2B Q9BVA1 3/20 0.41
▸ TUBB1 Q9H4B7 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2205092 0.84 HRH4 (0.56) ALOX5KIF11HRH4MEN1KMT2A
SCHEMBL2440393 0.80 HRH4 (0.52) ALOX5KIF11HRH4MEN1KMT2A
SCHEMBL30310659 0.74 HRH4 (0.55) KIF11HRH4MEN1KMT2ANR4A2
SCHEMBL2134591 0.74 FLT3 (0.58) KIF11MEN1KMT2ANR4A2FLT3
SCHEMBL915460 0.74 HRH4 (0.55) KIF11HRH4MEN1KMT2ANR4A2
SCHEMBL23049701 0.73 PARP1 (0.48) ALOX5KIF11MEN1KMT2ANR4A2
SCHEMBL8655451 0.73 HRH4 (0.56) KIF11HRH4MEN1KMT2ANR4A2
SCHEMBL5568273 0.73 FLT3 (0.59) ALOX5KIF11HRH4NR4A2FLT3
SCHEMBL2323348 0.73 FLT3 (0.59) ALOX5KIF11HRH4NR4A2FLT3
SCHEMBL217459 0.73 FLT3 (0.66) HRH4MEN1KMT2AFLT3ULK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040133014-A1 3-Sulfenylation of indole-2-carboxylates WALL HAMILTON HARRIET (US) 2004-07-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040133014-A1 3-Sulfenylation of indole-2-carboxylates TST, IDO2, INMT ALOX5 2168/4885KIF11 2998/4885HRH4 1650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback